Examkin

Soru

Zorluk: OrtaGeneral Internal Medicine

A 65-year-old man with a history of stage 4 chronic kidney disease and heart failure with reduced ejection fraction is brought to the emergency department due to profound muscle weakness and palpitations. His home medications include lisinopril, spironolactone, and carvedilol. Vital signs show a blood pressure of 110/70 mmHg110/70 \text{ mmHg} and a heart rate of 52/min52/\text{min}. An electrocardiogram reveals sinus bradycardia with peaked T waves and widened QRS complexes. Laboratory studies demonstrate a serum potassium level of 7.6 mEq/L7.6 \text{ mEq/L} and a serum creatinine of 3.4 mg/dL3.4 \text{ mg/dL} (baseline 2.2 mg/dL2.2 \text{ mg/dL}). Arrange the following pharmacological interventions in the most appropriate chronological order for this patient's acute management.

  1. 1Administration of intravenous calcium gluconate
  2. 2Administration of intravenous regular insulin and 50% dextrose
  3. 3Administration of oral sodium zirconium cyclosilicate

Cevap

The correct sequence for the acute management of severe hyperkalemia with ECG changes is: 1) Intravenous calcium gluconate, 2) Intravenous regular insulin and 50% dextrose, and 3) Oral sodium zirconium cyclosilicate.
The correct sequence prioritizes immediate survival followed by definitive treatment. Calcium gluconate acts within 1-3 minutes to stabilize the resting membrane potential of cardiomyocytes, making it the indispensable first step for patients with hyperkalemic ECG changes (like widened QRS). Intracellular shifting agents (insulin/dextrose) act within 15-30 minutes to temporarily hide potassium inside cells, providing a medium-term bridge. Finally, potassium-removing agents (like sodium zirconium cyclosilicate) take hours to work but definitively clear the excess potassium from the body.

Adım Adım Çözüm

1
Identify the life-threatening emergency based on clinical and laboratory data.
The patient has severe hyperkalemia (7.6 mEq/L7.6 \text{ mEq/L}) complicated by cardiac toxicity, evidenced by peaked T waves and widened QRS complexes on the electrocardiogram.
Widened QRS complexes indicate impending fatal ventricular arrhythmias, dictating an immediate, stepwise resuscitation protocol.
2
Determine the most critical first intervention to prevent mortality.
Intravenous calcium gluconate is administered first.
Calcium directly antagonizes the membrane actions of hyperkalemia without lowering serum potassium levels, rapidly stabilizing the cardiac myocardium and narrowing the QRS complex within minutes.
3
Determine the next step to acutely lower extracellular potassium.
Intravenous regular insulin combined with 50% dextrose is administered second.
Once the cardiac membrane is protected, potassium must be rapidly shifted into cells. Insulin drives potassium intracellularly within 15-30 minutes, providing a critical temporary bridge. Dextrose is given to prevent profound hypoglycemia.
4
Determine the final step for definitive resolution.
Oral sodium zirconium cyclosilicate (or another potassium-removing therapy) is administered last.
Membrane stabilization and intracellular shifting are transient measures. Definitive removal of total body potassium via gastrointestinal cation exchangers, loop diuretics, or hemodialysis is required for sustained correction.

Anahtar Kavram

The sequential management of severe hyperkalemia with ECG changes relies on a three-phase approach: cardiac membrane stabilization (calcium), intracellular shifting (insulin/dextrose, albuterol), and definitive total body removal (cation exchangers, diuretics, dialysis).
Bu soruyu puanla

Konular

General Internal Medicine

Bu konudan daha fazla soru